Pancreatic Cancer

• Pancreatic cancer
• Novel Strategies Tested To Boost Checkpoint Inhibitor Efficacy
• Patterns of treatment outcomes in older patients with metastatic pancreatic cancer (231P)
• Dacomitinib, a pan-ErbB inhibitor, inhibits proliferation and invasion of pancreatic ductal adenocarcinoma cells (232P)
• Real-world experience with FOLFIRINOX and gemcitabine plus nab-paclitaxel in the treatment of pancreatic cancer in Japan (233P)
• Efficacy of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: a single institution experience from a third world country. (234P)
• Association between Opioid Use and Survival Time in Patients with Unresectable Pancreatic Cancer: 10 Years of Clinical Experience (468P)
• Clinical Utility of PET/CT and Diagnostic Laparoscopy in Pancreatic Cancer Staging (235P)
• CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) _ 5-fluorouracil and leucovorin (5-FU/LV) in meta...
• Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: a phase 3 study of nal-IRI_5-fluorouracil/leucovorin in patients with meta...
• Gemcitabine + Nab-Paclitaxel for advanced pancreatic cancer - A retrospective audit of dose intensity, toxicity and efficacy. (229P)
• Dose intensity and initial treatment effect of FOLFIRINOX supported with pegfilgrastim for patients with pancreatic ductal adenocarcinoma (230P)
• C4orf47 contributes to the induction of malignant phenotypes in pancreatic cancer (236P)
• Personalized peptide vaccine induced adoptive immunocyte transfer combined chemotherapy and radiation improved the survival of advanced pancreatic...
• Three-dimensional remnant pancreatic volumetry predicts the short-term outcomes of pancreatic cancer patients after pancreatoduodenectomy (238P)
• A liquid biopsy gene panel for pancreatic cancer detection (30P)
• Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of PEGylated Recombinant Human Hyaluronidase PH20 (PEGPH20)+nab-Paclitaxel/Gemcitabine...
• Pancreatic Cancer
• Gene Alterations Influence Postoperative Pancreatic Cancer Survival
• nab-Paclitaxel (nab-P) Plus Gemcitabine (G) for Patients (Pts) With Locally Advanced Pancreatic Cancer (LAPC): Interim Efficacy and Safety Results...
• A phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the t...
• A Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT...
• A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
• Liprin-α4 could be a potential therapeutic target for pancreatic cancer
• Could a Systemic Inflammation Response Index (SIRI) predict Overall Survival (OS) in metastatic Pancreatic Cancer (PC)?

• « Previous
• 1
• 2
• ...
• 16
• Next »